Notices. Notice
378 words·~2 min read·
/register/2017/05/30/2017-11011A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2016-N-2544; FDA-2013-N-0823; FDA-2013-N-0795; FDA-2013-N-1147; FDA-2013-N-1064; FDA-2008-D-0150; FDA-2013-N-0663; FDA-2010-D-0319; FDA-2013-N-0403; FDA-2012-D-0530; FDA-2016-N-0544] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 11601 Landsdown St., North Bethesda, MD 20852,301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under § 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the Internet at *http://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved By OMB Title of collection OMB control No. Date approval expires Current Good Manufacturing Practice; Quality System Regulation 0910-0073 1/31/2020 Format and Content Requirements for Over-the-Counter Drug Product Labeling 0910-0340 1/31/2020 Medical Devices; Third Party Review Under FDAMA 0910-0375 1/31/2020 Preparing a Claim of Categorical Exclusion or an Environmental Assessment for Submission to the Center for Food Safety and Applied Nutrition 0910-0541 1/31/2020 Application for Participation in the Medical Device Fellowship Program; Form FDA 3608 0910-0551 1/31/2020 GFI: Hypertension Indication; Drug Labeling for Cardiovascular Outcome Claims 0910-0670 1/31/2020 Investigational New Drug Safety Reporting Requirements for Human Drug and Biological Products and Safety Reporting Requirements for Bioavailability and Bioequivalence Studies in Humans 0910-0672 1/31/2020 GFI: Dear Health Care Provider Letters; Improving Communication of Important Safety Information 0910-0754 1/31/2020 Protection of Human Subjects: Informed Consent; Institutional Review Boards 0910-0755 1/31/2020 Requests for Feedback on Medical Device Submissions 0910-0756 1/31/2020 National Direct-to-Consumer Advertising Survey 0910-0828 1/31/2020 Dated: May 23, 2017. Anna K. Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis. [FR Doc. 2017-11011 Filed 5-26-17; 8:45 am]
Connectionstraces to 1
Traces to 1 document